NOD1 and Alzheimer disease: In addition, although the expression level of NOD1 in AD-MSC-, AD-CM-, BM-MSC-, and BM-CM-treated groups was significantly lower than the IL-1β-induced Caco-2 group, it was still significantly higher than the control group.